2nd Quarter - Report — THE NICKLES GROUP, LLC for UCB, INC. (2021)

Firm

THE NICKLES GROUP, LLC

Client

UCB, INC.

Income

$60,000

Expenses

—

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

Monitored the American Jobs Plan, as it relates to corporate and international taxes.

Lobbyist	Covered position, as disclosed
RACHEL JONES HENSLER	—

Contacted: Centers For Medicare and Medicaid Services (CMS); SENATE; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS)

Health Issues HCR

S. 464 / H.R. 2163, the Safe Step Act and issues related to step therapy.

Lobbyist	Covered position, as disclosed
GREG D'ANGELO	—
MARY BETH SAVARY TAYLOR	—

Contacted: HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); SENATE; Centers For Medicare and Medicaid Services (CMS)

Bills named: S. 464 (117th), H.R. 2163 (117th)

Issues related to COVID-19 and access to Part B drugs; issues related to reimbursement of self-administered drugs; issues related to Part D drugs and protected classes. Monitored issues related to Medicare sequestration. Issues related to value-based payment arrangements. Monitored issues related to P.L. 116-260, the Consolidated Appropriations Act of 2021. Monitored drug pricing issues related to H.R. 3, the Elijah E. Cummings Lower Drug Costs Now Act and H.R. 19/S. 2164, the Lower Costs, More Cures Act.

Lobbyist	Covered position, as disclosed
GREG D'ANGELO	—
MARY BETH SAVARY TAYLOR New	Joint Economic Committee, General Counsel; U.S. Senator Connie Mack, Legislative Assistant.

Contacted: Centers For Medicare and Medicaid Services (CMS); SENATE; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES

Bills named: S. 2164 (117th), H.R. 3 (117th), H.R. 19 (117th)

Government Issues GOV

Issues related to COVID-19 and access to Part B drugs, including issues related to reimbursement of self-administered drugs. Monitored issues related to P.L. 116-260, the Consolidated Appropriations Act of 2021. Monitored drug pricing issues related to H.R. 3, the Elijah E. Cummings Lower Drug Costs Now Act and H.R.19, the Lower Costs, More Cures Act. H.R. 2163, the Safe Step Act and issues related to step therapy. Monitored FY 2022 Budget Resolution.

Lobbyist	Covered position, as disclosed
BRETT BAKER New	U.S. Senate Committee on Finance (Senators Crapo, Grassley, and Hatch)-Deputy Health Policy Director; Health Policy Dir.; Senior Policy Advsr; Policy Advisor. U.S. House of Representatives Committee on Ways and Means (Reps. Camp and Ryan) Prof. Staff

Contacted: HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); SENATE

Bills named: H.R. 2163 (117th), H.R. 19 (117th), H.R. 3 (117th)

Budget/Appropriations BUD

Monitored FY 2022 Budget Resolution.

Lobbyist	Covered position, as disclosed
GREG D'ANGELO	—
RACHEL JONES HENSLER	—
MARY BETH SAVARY TAYLOR	—

Contacted: Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.